-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Enveric Biosciences, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2014 to Q2 2025.
- Enveric Biosciences, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2025 was -0.97 USD/shares, a 73.9% increase year-over-year.
- Enveric Biosciences, Inc. Earnings Per Share, Diluted for the twelve months ending June 30, 2025 was -8 USD/shares, a 93.6% increase year-over-year.
- Enveric Biosciences, Inc. annual Earnings Per Share, Diluted for 2024 was -19 USD/shares, a 84.3% increase from 2023.
- Enveric Biosciences, Inc. annual Earnings Per Share, Diluted for 2023 was -121 USD/shares, a 833% decline from 2022.
- Enveric Biosciences, Inc. annual Earnings Per Share, Diluted for 2022 was -13 USD/shares.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)